Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
US7928078B2 · kind B2 · utility
0Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2008 |
| Grant date | Apr 19, 2011 |
| Priority date | — |
| Expiry date | Dec 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.